.Invite to today's Chutes & Ladders, our roundup of significant leadership hirings, shootings and...
.Observing a poor presenting for Lykos Therapeutics' MDMA candidate for trauma at a latest FDA consu...
.AN2 Therapies is actually reviewing its own organization in feedback to uninspired midphase data, p...
.Merck & Co. is spending $700 million in advance to challenge Amgen in a blood stream cancer mark...
.Along With Gilead Sciences on the verge of an FDA selection for its own liver illness drug seladelp...
.Chief executive officer David Ricks can find the providers setting up camping tents at basecamp beh...
.Mattress Liquidators has actually turned Entero Therapies white colored as a piece. The lender boug...
.Exelixis is giving up on its tissue variable (TF)- targeting antibody-drug conjugate after wrapping...
.3 full weeks after Roche's Genentech device ignored an SHP2 inhibitor pact, Relay Therapeutics has ...
.Stoke Therapies' Dravet disorder medicine has actually been devoid of a predisposed grip, clearing ...